Showing results (211-220 of 242) with videos related to

Sort By:
Pageof 25
The Journal of Obstetrics and Gynaecology Research|January 11, 2021
Is the extent of lymphadenectomy a prognostic factor in International Federation of Gynecology and Obstetrics stage II endometrioid endometrial cancer?Zeliha Firat Cuylan, Huseyin Akilli, Kemal Gungorduk, et al.
Journal of Clinical Medicine|February 27, 2026
Efficacy, Safety, and Survival Outcomes of Immune Checkpoint Inhibitors in Patients with Mismatch Repair-Deficient Colorectal Cancer: A Retrospective, Multicenter StudyMehmet Cihan İcli, Deniz Can Guven, Arif Akyildiz, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 21, 2017
Oncological Outcomes of Stage II Endometrial Cancer: A Retrospective Analysis of 250 CasesNejat Ozgul, Gokhan Boyraz, Mehmet Coskun Salman, et al.
Archives of Gynecology and Obstetrics|September 4, 2017
What is the impact of stromal microinvasion on oncologic outcomes in borderline ovarian tumors? A multicenter case-control studyGokhan Boyraz, Mehmet Coskun Salman, Murat Gultekin, et al.
Cancer Management and Research|April 3, 2026
Prognostic Impact of Cetuximab-Related Hypomagnesemia and Hypokalemia in RAS/RAF Wild-Type Colorectal Cancer: A Multicenter StudyHalil Göksel Güzel, Derya Kıvrak Salim, Ece Ulukal Karancı, et al.
Archives of Gynecology and Obstetrics|August 27, 2021
Survival outcomes of women with grade 3 endometrioid endometrial cancer: the impact of adjuvant treatment strategiesKemal Gungorduk, Jumana Muallem, Osman Aşıcıoğlu, et al.
Current Problems in Cancer|March 9, 2021
Prognostic factors and survival outcomes of women with uterine leiomyosarcoma: A Turkish Uterine Sarcoma Group Study-003Ali Ayhan, Kemal Gungorduk, Ghanim Khatib, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 5, 2019
SATEN III-Splitting Adjuvant Treatment of stage III ENdometrial cancers: an international, multicenter studyIlker Kahramanoglu, Mehmet Mutlu Meydanli, Siarhei Taranenka, et al.
Frontiers in Immunology|March 2, 2026
Baseline glucose-to-lymphocyte ratio predicts nivolumab outcomes in advanced non-small cell lung cancer: a multicenter retrospective studyMustafa Ersoy, Umut Kefeli, Devrim Cabuk, et al.
Journal of Gynecologic Oncology|May 26, 2017
Prognostic factors and treatment outcomes in surgically-staged non-invasive uterine clear cell carcinoma: a Turkish Gynecologic Oncology Group studyMustafa Erkan Sarı, Mehmet Mutlu Meydanlı, Osman Türkmen, et al.
Pageof 25